These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 8033137

  • 1. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
    Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Uskokovic MR, Brenner RV, Evans SR.
    Cancer Res; 1994 Aug 01; 54(15):4057-64. PubMed ID: 8033137
    [Abstract] [Full Text] [Related]

  • 2. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG, Redlich K, Schiller C, Chirayath MV, Uskokovic M, Peterlik M, Cross HS.
    J Pharmacol Exp Ther; 1995 Dec 01; 275(3):1254-60. PubMed ID: 8531089
    [Abstract] [Full Text] [Related]

  • 3. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.
    Evans SR, Schwartz AM, Shchepotin EI, Uskokovic M, Shchepotin IB.
    Clin Cancer Res; 1998 Nov 01; 4(11):2869-76. PubMed ID: 9829754
    [Abstract] [Full Text] [Related]

  • 4. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A.
    Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699
    [Abstract] [Full Text] [Related]

  • 5. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition.
    Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR.
    Cancer Res; 1993 Aug 15; 53(16):3712-8. PubMed ID: 8393379
    [Abstract] [Full Text] [Related]

  • 6. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 7. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M, Uskokovic M, Hisatake J, Hisatake Y, Koike K, Komiyama A, Koeffler HP.
    Cancer Res; 2001 Apr 15; 61(8):3361-8. PubMed ID: 11309293
    [Abstract] [Full Text] [Related]

  • 8. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS, Rao DS, Siu-Caldera ML, Astecker N, Weiskopf A, Vouros P, Sasso GJ, Manchand PS, Uskokovic MR.
    Arch Biochem Biophys; 2000 Nov 15; 383(2):197-205. PubMed ID: 11185554
    [Abstract] [Full Text] [Related]

  • 9. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Nov 15; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 10. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo.
    Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR.
    Urology; 1995 Sep 15; 46(3):365-9. PubMed ID: 7660511
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R, Subhashini J, Roy KR, Reddy GS, Robinson M, Uskokovic MR, Venkateswara Reddy G, Reddanna P.
    J Cell Biochem; 2008 Aug 01; 104(5):1832-42. PubMed ID: 18348265
    [Abstract] [Full Text] [Related]

  • 12. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3.
    Sokoloski JA, Shyam K, Sartorelli AC.
    Oncol Res; 1997 Aug 01; 9(1):31-9. PubMed ID: 9112258
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of HT-29 human colon cancer growth under the renal capsule of severe combined immunodeficient mice by an analogue of 1,25-dihydroxyvitamin D3, DD-003.
    Tanaka Y, Wu AY, Ikekawa N, Iseki K, Kawai M, Kobayashi Y.
    Cancer Res; 1994 Oct 01; 54(19):5148-53. PubMed ID: 7923132
    [Abstract] [Full Text] [Related]

  • 14. Synthetic analogs of vitamin D3 have inhibitory effects on breast cancer cell lines.
    Fioravanti L, Miodini P, Cappelletti V, DiFronzo G.
    Anticancer Res; 1998 Oct 01; 18(3A):1703-8. PubMed ID: 9673393
    [Abstract] [Full Text] [Related]

  • 15. 19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines.
    Koike M, Elstner E, Campbell MJ, Asou H, Uskokovic M, Tsuruoka N, Koeffler HP.
    Cancer Res; 1997 Oct 15; 57(20):4545-50. PubMed ID: 9377567
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
    Evans SR, Houghton AM, Schumaker L, Brenner RV, Buras RR, Davoodi F, Nauta RJ, Shabahang M.
    J Surg Res; 1996 Feb 15; 61(1):127-33. PubMed ID: 8769954
    [Abstract] [Full Text] [Related]

  • 17. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 18. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.
    Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP.
    Cancer Epidemiol Biomarkers Prev; 1997 Sep 01; 6(9):727-32. PubMed ID: 9298581
    [Abstract] [Full Text] [Related]

  • 19. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 01; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 20. Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.
    Hedlund TE, Moffatt KA, Uskokovic MR, Miller GJ.
    Clin Cancer Res; 1997 Aug 01; 3(8):1331-8. PubMed ID: 9815816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.